Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
While several small molecular inhibitors targeting specifically KRAS G12C have been developed and tested clinically, alternative approaches are still necessary due to expected drug resistance
Additional preclinical research has examined the compound in energy homeostasis, appetite suppression, and peripheral metabolic signalling models
awake conditions remains unclear, which may be related to neuromodulator influences associated with brain status
Wondering how it works
US$ 21.69
US$ 24.84
US$ 22.39
US$ 26.27
US$ 20.33
US$ 24.09
US$ 28.52
